Skip to main content


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Full Schedule

Full Schedule

  • Thursday, November 3, 2022
  • 1:30 PM – 7:00 PM CDT
    Registration Open
  • 5:00 PM – 6:00 PM CDT
    Welcome and First-time Attendee Happy Hour (In-person Only)
  • 6:00 PM – 7:00 PM CDT
    A First-line Treatment Option for Your Adult Patients With Advanced Renal Cell Carcinoma - Supported by Eisai

    Industry Sponsored Session

    Online Only Session

  • 7:00 PM – 8:00 PM CDT
    RCC Clinical Consults: Making Difficult Treatment Decisions at the Intersection of the Data and the Real World - CME Session Provided by PeerView Oncology

    Moderator: Sumanta Kumar Pal, FASCO – City of Hope

    Industry Sponsored Session

    Hybrid Session

  • Friday, November 4, 2022
  • 6:30 AM – 6:30 PM CDT
    Registration Open
  • 6:30 AM – 6:45 PM CDT
    Poster and Exhibit Hall Open
  • 6:45 AM – 7:45 AM CDT
    Women in RCC Networking

    Chair: Maria Carlo, MD – Memorial Sloan Kettering Cancer Center

    Speaker: W. Kimryn Rathmell, MD, PhD – Vanderbilt University Medical Center

    Speaker: Elaine Chang, MD – United States Food and Drug Administration

    Speaker: Vicki Goodman, MD (she/her/hers) – Exelixis

    Networking Session

    Hybrid Session

  • 7:45 AM – 8:00 AM CDT
    Break
  • 7:45 AM – 8:15 AM CDT
    Breakfast
  • 8:00 AM – 8:09 AM CDT
    Welcome to 2022 IKCS: North America
  • 8:10 AM – 9:57 AM CDT
    Session 1: Treatment Debates in RCC

    Chair: Vitaly Margulis, MD – University of Texas Southwestern

    Chair: Rana McKay, MD – UCSD

    CME Session

    Hybrid Session

  • 9:57 AM – 10:00 AM CDT
    Patient Perspective: Russ Nicholson
  • 10:00 AM – 11:00 AM CDT
    Session 2: Side-effect Management and Quality of Live Perspectives

    Chair: Elizabeth Wulff-Burchfield, MD – University of Kansas Medical Center

    CME Session

    Hybrid Session

  • 11:00 AM – 11:30 AM CDT
    Break
  • 11:30 AM – 11:50 AM CDT
    Session 3: The Professional State of RCC
  • 11:50 AM – 1:00 PM CDT
    Session 4: Professional Development Workshop (In-person Only)

    Chair: Eric A. Singer, MD, MA, MS, FACS, FASCO – The Ohio State University Comprehensive Cancer Center

    Chair: Tian Zhang, MD, MHS – University of Texas Southwestern Medical Center

    In-person Only Session

  • 1:00 PM – 1:15 PM CDT
    Break
  • 1:00 PM – 2:30 PM CDT
    Lunch and Posters
  • 1:15 PM – 2:15 PM CDT
    A Combination Treatment for Patients with Advanced Renal Cell Carcinoma - Supported by Exelixis

    Industry Sponsored Session

    Hybrid Session

  • 2:15 PM – 2:30 PM CDT
    Break
  • 2:30 PM – 3:15 PM CDT
    Session 5: Keynote

    Chair: Tian Zhang, MD, MHS – University of Texas Southwestern Medical Center

    CME Session

    Hybrid Session

  • 3:15 PM – 4:30 PM CDT
    Session 6: Multidisciplinary Team Approaches to Rare Subtypes

    Chair: Jodi Maranchie, MD – University of Pittsburgh Medical Center

    CME Session

    Hybrid Session

  • 4:30 PM – 5:15 PM CDT
    Session 7: Academy of Kidney Cancer Investigators

    Chair: Brian Rini, MD – Vanderbilt-Ingram Cancer Center

    CME Session

    Hybrid Session

  • 5:15 PM – 5:30 PM CDT
    Remembering Nicholas J. Vogelzang, MD, FASCO, FACP
  • 5:30 PM – 6:45 PM CDT
    Evening Networking Reception and Poster Viewing
  • 5:45 PM – 6:30 PM CDT
    Poster Walks (In-person Only)
  • 5:45 PM – 6:30 PM CDT
    Poster Walks (Online Only)
  • 6:00 PM – 7:00 PM CDT
    A Treatment Option for Certain Patients With RCC in the Adjuvant Setting - Supported by Merck

    Industry Sponsored Session

    In-person Only Session

  • Saturday, November 5, 2022
  • 6:30 AM – 7:15 AM CDT
    Run (In-person Only, Advance Registration Required)
  • 6:30 AM – 7:30 AM CDT
    Yoga (In-person Only, Advance Purchase Required)
  • 6:30 AM – 2:00 PM CDT
    Poster and Exhibit Hall Open
  • 6:30 AM – 2:00 PM CDT
    Registration Open
  • 7:45 AM – 8:15 AM CDT
    Breakfast
  • 8:00 AM – 8:15 AM CDT
    Welcome to Day 2 and Updates from the Kidney Cancer Association
  • 8:15 AM – 9:15 AM CDT
    Session 8: Regulatory for New Trials

    Chair: Sumanta Kumar Pal, FASCO – City of Hope

    CME Session

    Hybrid Session

  • 9:15 AM – 10:00 AM CDT
    Session 9: Oral Abstract Session

    Chair: Yousef Zakharia, MD – University of Iowa

    CME Session

    Hybrid Session

  • 10:00 AM – 10:05 AM CDT
    Patient Perspective: Tom Cady
  • 10:05 AM – 10:15 AM CDT
    Break
  • 10:15 AM – 11:45 AM CDT
    Session 10: Genetics in Kidney Cancer Demonstrated Through Case-Based Presentations

    Chair: Maria Carlo, MD – Memorial Sloan Kettering Cancer Center

    CME Session

    Hybrid Session

  • 11:45 AM – 12:30 PM CDT
    Session 11: Risk Stratification: Considerations and the Evolving State of RCC

    Chair: Katy Beckermann, MD, PhD – Vanderbilt University Medical Center

    CME Session

    Hybrid Session

  • 12:30 PM – 1:30 PM CDT
    Break and Lunch Available
  • 12:45 PM – 1:25 PM CDT
    Session 12: Kidney Cancer Association Awards Recognition

    CME Session

    Hybrid Session

  • 1:25 PM – 2:25 PM CDT
    Session 13: WoodFire®

    CME Session

    Hybrid Session

  • 2:25 PM – 2:40 PM CDT
    Meeting Closing